[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"breast-cancer-diagnosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:breast-cancer-diagnosis":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,42,74,101],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100559048","evaluating-the-implementation-of-a-comprehensive-multilevel-virtual-oncology-program-among-veterans-diagnosed-with-lung-colorectal-prostate-and-breast-cancers-in-the-us-department-of-veterans-affairs-100559048",false,"NCT06559059","Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs","Patients Inclusion Criteria:\n\n1. A Veteran\n2. Aged 18 years or older\n3. Newly diagnosed with lung, prostate, breast, or colon cancer within 3 months of telemedicine visit\n4. Engaged in an oncology visit during the 36-month analysis period at a Veterans Affairs Medical Center (VAMC) location.\n\nVAMC Providers and Staff Inclusion Criteria:\n\n1. Provider or staff member at one of the VAMC locations including physicians, nurse practitioners, physicians' assistants, and nurses caring for Veterans\n2. Providers or staff members having helped provide care for at least 5 Veterans with cancer in the previous 6 months at a VAMC location\n\nPatients Exclusion Criteria:\n\n1. Veterans who have not seen any providers in the VA within the past year\n2. Patients previously diagnosed with lung, prostate, breast, or colon cancer\n3. Pregnant patients\n\nVAMC Providers and Staff Exclusion Criteria:\n\n1\\. Providers or staff members who do not help treat Veterans with specified cancers in oncology at the VA","ALL","18 Years",{"count":18,"type":19},1800,"ESTIMATED","INTERVENTIONAL",[22],"NA","The objective of the pragmatic trial to test the effectiveness of an existing, ongoing clinical service, the VA National TeleOncology program (NTO), a multilevel telehealth population health management program. The primary aims are to study the intervention and determine its effectiveness on telehealth engagement, clinical quality, and healthcare cost outcomes across personal characteristics.",[25,26,27,28],"Lung Cancer Diagnosis","Colorectal Cancer (Diagnosis)","Prostate Cancer Diagnosis","Breast Cancer Diagnosis","RECRUITING","2026-06-01",{"date":32,"type":33},"2026-06-03","ACTUAL",{"date":35,"type":33},"2024-06-18",{"date":37,"type":19},"2027-07-31",{"name":39,"class":40},"NYU Langone Health","OTHER",5,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":49,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":50,"targetDuration":52,"studyType":53,"phases":4,"briefSummary":54,"conditions":55,"keywords":61,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":73},"100609461","ucf-mammochat-image-repository-100609461","NCT07214883","UCF MammoChat: Image Repository","UCF MammoChat: An AI-Driven Platform for Personalized Breast Cancer Patient Support -Image Repository","Inclusion Criteria:\n\n* Adults, ages 18 and older\n* Had a radiographic breast cancer imaging test, either for screening or diagnosis of breast cancer, with either positive or negative results performed in a US institution.\n* Have an email account with access to a reliable internet connection or smartphone\n* Pregnant women may choose to participate.\n\nExclusion Criteria:\n\n* Minors , ages under 18\n* Prisoners\n* Adults who are unable to provide consent.",true,{"count":51,"type":19},20000,"1 Year","OBSERVATIONAL","This study aims to develop AI models to better read diagnostic mammograms for various populations and types of breast cancer, using the images that participants donate and their responses from study questionnaire to improve patient outcomes. This study also aims to provide mammography images to participants.",[56,57,58,59,60,28],"Breast Cancer","Breast Cancer Awareness","Breast Cancer Detection","Breast Cancer Survivors","Breast Cancer Female",[56,62,63],"Artificial Intelligence","AI","2025-10-08",{"date":66,"type":33},"2025-10-09",{"date":68,"type":33},"2025-09-03",{"date":70,"type":19},"2026-06-30",{"name":72,"class":40},"University of Central Florida",1,{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":78,"acronym":4,"eligibilityCriteria":79,"healthyVolunteers":49,"sex":15,"minAge":16,"maxAge":80,"enrollmentInfo":81,"targetDuration":83,"studyType":53,"phases":4,"briefSummary":84,"conditions":85,"keywords":87,"overallStatus":91,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":4},"100595576","electrochemical-biosensor-based-on-lectin-functionalized-nitrogen-sulfur-doped-graphene-quantum-dot-decorated-gold-nanoparticles-for-breast-cancer-diagnosis-from-academic-research-to-clinical-translation-100595576","NCT07034248","Electrochemical Biosensor Based on Lectin-functionalized Nitrogen, Sulfur-doped Graphene Quantum Dot Decorated Gold Nanoparticles for Breast Cancer Diagnosis: From Academic Research to Clinical Translation","Inclusion Criteria:\n\n* age 18-90\n* health participants: without cancer over 5 years\n* cancer participants: diagnosis of breast cancer\n* cancer participants: agree to receive treatment in Chang Gung hospital\n\nExclusion Criteria:\n\n* mental disease\n* Physician's assessment not suitable","90 Years",{"count":82,"type":19},240,"3 Years","In this research, considering benefits of the nitrogen, sulfur-doped graphene quantum dot (NSGQDs) and 3-dimensional gold nanoparticle (AuNP), we used these materials for the construction of a novel electrochemical biosensor to apply the synergy contributions on the enhancement of the potential in clinical and cancer diagnostic applications. The synthesis of a novel nanocomposite through the integration of NSGQDs with AuNP yields a hybrid material (NSGQDs\u002FAuNP) that combines the advantages of both its organic and inorganic properties, potentially revealing unique characteristics to enhance the electrochemical behaviors, which establishes a robust foundation for constructing a label-free electrochemical biosensor. This pioneering biosensor was then conjugated with PhaL (NSGQDs\u002FAuNP\u002FPhaL) through the amide bond between the COOH group of NSGQDs and the NH2 group of PhaL, which has the potential for the ultra-sensitive detection of cancer markers, featuring heightened electrochemical and sensing capabilities that make substantial contributions to the field of cancer detection. The detection principle of breast cancer is based on the change in impedance of NSGQDs\u002FAuNP\u002FPhaL after the addition of breast cancer cell, which can inhibit the electron transfer after the formation of breast cancer cell bioconjugate with NSGQDs\u002FAuNP\u002FPhaL. NSGQDs\u002FAuNP\u002FPhaL are used as the bi-functional probe to amplify the electrochemical activity as well as to link cancer cell. The developed novel NSGQDs\u002FAuNP\u002FPhaL biosensor show high sensitivity and good stability for quantitative determination of breast cancer cell in a linear range of 5 - 2500 cell mL-1 with limit of detection (LOD) of 6 cancer cell mL-1, which exhibits a great potential in clinical and cancer diagnostic applications. The superior sensitivity of the developed impedimetric immunosensor is mainly attributed to the remarkable electro-conductivity of NSGQDs\u002FAuNP, which can accelerate the electron transfer process between NSGQDs\u002FAuNP\u002FPhaL and electrolyte. This achievement paves the way for the development of a lectin-based sensing probe as a robust platform for the ultrasensitive and selective detection of MCF-7 and other cancer cell lines. Such advancements hold significant promise for facilitating early diagnosis and therapy of diseases, particularly in the context of breast cancer.",[86,28],"Electrochemically Sensing Prob",[88,89,90],"Electrochemically sensing prob","sulfur-doped graphene quantum dots","breast cancer diagnosis","NOT_YET_RECRUITING","2025-07-15",{"date":94,"type":33},"2025-07-18",{"date":96,"type":19},"2025-07-20",{"date":98,"type":19},"2030-07-31",{"name":100,"class":40},"Chang Gung Memorial Hospital",{"id":102,"slug":103,"hasResults":11,"nctId":104,"briefTitle":105,"officialTitle":105,"acronym":4,"eligibilityCriteria":106,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":107,"targetDuration":109,"studyType":53,"phases":4,"briefSummary":110,"conditions":111,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":115,"completionDateStruct":117,"leadSponsor":119,"locationsCount":73},"100275771","institut-paoli-calmettes-breast-cancer-database-100275771","NCT02869607","Institut Paoli Calmettes Breast Cancer Database","Inclusion Criteria:\n\n* Patient with a diagnosis of breast cancer\n\nExclusion Criteria:\n\n\\-",{"count":108,"type":19},45000,"10 Years","Database of Institut Paoli-Calmettes patients diagnosed with breast cancer",[28],"2016-08-16",{"date":114,"type":19},"2016-08-17",{"date":116,"type":4},"1995-01",{"date":118,"type":19},"2030-12",{"name":120,"class":40},"Institut Paoli-Calmettes"]